Ronald Muhlenkamp - Muhlenkamp & Co 13F Activity & Position Changes (Q4 2022)

As of Dec 31, 2022, the Muhlenkamp & Co portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Jan 31, 2023. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q4 2022, the filing reported:

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date Symbol Type Change Qty
Q4 2022
AAPL
Apple Inc.
Sell
-56
Q4 2022
AMLP
Alerian MLP ETF
Buy
+260
Q4 2022
AVGO
Broadcom Inc.
Sell
-16
Q4 2022
BMY
Bristol-Myers Squibb Company
Buy
+197
Q4 2022
BRK-B
Berkshire Hathaway Inc. New
Buy
+36
Q4 2022
CCJ
Cameco Corporation
Sell
-159
Q4 2022
CVS
CVS Health Corporation
Buy
+122
Q4 2022
DOW
Dow Inc.
Sell
-199
Q4 2022
EQT
EQT Corporation
Sell
-451
Q4 2022
FNV
Franco-Nevada Corporation
Buy
+71
Q4 2022
GLD
SPDR Gold Trust
Sell
-53
Q4 2022
KEX
Kirby Corporation
Sell
-154
Q4 2022
MCHP
Microchip Technology Incorporat
Sell
-112
Q4 2022
MCK
McKesson Corporation
Buy
+40
Q4 2022
MSFT
Microsoft Corporation
Sell
-21
Q4 2022
MTZ
MasTec, Inc.
Sell
-124
Q4 2022
NMIH
NMI Holdings Inc
Sell
-196
Q4 2022
OXY
Occidental Petroleum Corporatio
Sell
-237
Q4 2022
RGLD
Royal Gold, Inc.
Buy
+77
Q4 2022
RUSHB
Rush Enterprises, Inc.
Sell
-252
Q4 2022
SLB
Schlumberger N.V.
Sell
-294
Q4 2022
SPDN
Direxion Daily S&P 500 Bear 1X
Sell - Position Exit
-652,921
Q4 2022
UNH
UnitedHealth Group Incorporated
Buy
+19
Q4 2022
WAB
Westinghouse Air Brake Technolo
Sell
-33
Q4 2022
XOM
Exxon Mobil Corporation
Buy - Position Entry
+1,952